Insulin-like growth factor type-1 receptor transactivation in vasoactive peptide and oxidant-induced signaling pathways in vascular smooth muscle cells

By Azar Zeina M.   Mehdi Mohamad Z.   Srivastava Ashok K.  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 1, 2007-01 ,pp. : 105-111

NRC Research Press

Access to resources Recommend Favorite

Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels

By Gonzalez W.   Soleilhac J.-M.   Fournie-Zaluski M.-C.   Roques B.P.   Michel J.-B.  

European Journal of Pharmacology, Vol. 345, Iss. 3, 1998-03 ,pp. : 323-331

Elsevier

Access to resources Recommend Favorite

Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-01 ,pp. : 3331-3348

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelin-1-(1-31), a novel vasoactive peptide, increases [Ca 2+ ] i in human coronary artery smooth muscle cells

By Yoshizumi M.   Inui D.   Okishima N.   Houchi H.   Tsuchiya K.   Wakabayashi H.   Kido H.   Tamaki T.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 305-309

Elsevier

Access to resources Recommend Favorite

Effect of vascular endothelial growth factor and epidermal growth factor on iatrogenic apoptosis in human endothelial cells

By Vinci M.C.   Visentin B.   Cusinato F.   Nardelli G.B.   Trevisi L.   Luciani S.  

Biochemical Pharmacology, Vol. 67, Iss. 2, 2004-01 ,pp. : 277-284

Elsevier

Access to resources Recommend Favorite